Author: Julian Braun; Lucie Loyal; Marco Frentsch; Daniel Wendisch; Philipp Georg; Florian Kurth; Stefan Hippenstiel; Manuela Dingeldey; Beate Kruse; Florent Fauchere; Emre Baysal; Maike Mangold; Larissa Henze; Roland Lauster; Marcus Mall; Kirsten Beyer; Jobst Roehmel; Juergen Schmitz; Stefan Miltenyi; Marcel A Mueller; Martin Witzenrath; Norbert Suttorp; Florian Kern; Ulf Reimer; Holger Wenschuh; Christian Drosten; Victor M Corman; Claudia Giesecke-Thiel; Leif-Erik Sander; Andreas Thiel
Title: Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors Document date: 2020_4_22
ID: 164yx77a_38
Snippet: prospective studies to assess the contribution of pre-existing SARS-CoV-2-cross-reactive 199 immunity (potential regional differences) to clinical outcomes of SARS-CoV-2-infections......
Document: prospective studies to assess the contribution of pre-existing SARS-CoV-2-cross-reactive 199 immunity (potential regional differences) to clinical outcomes of SARS-CoV-2-infections.
Search related documents:
Co phrase search for related documents- clinical outcome and SARS clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- clinical outcome and SARS reactive: 1, 2, 3, 4, 5, 6
- potential regional difference and regional difference: 1
- prospective study and regional difference: 1
- prospective study and SARS clinical outcome: 1, 2, 3, 4, 5, 6
- prospective study and SARS reactive: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date